Preventing glaucoma with diabetes drugs

A popular class of diabetes medications called GLP-1R agonists may also protect against glaucoma in people with diabetes.

Researchers from the Scheie Eye Institute at the University of Pennsylvania’s Perelman School of Medicine examined retrospective data of 1,961 people with diabetes new to GLP-1R agonists (Trulicity and Rybelsus) and matched them to 4,371 unexposed control subjects. After 150 days on average, 10 people in the medicated group were newly diagnosed with glaucoma compared to 58 patients in the control group. This suggests that GLP-1 receptor agonists may decrease a person’s risk of developing glaucoma by half.

The findings were published in the British Journal of Ophthalmology. To read the study, CLICK HERE

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).
Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags